Elicio Therapeutics, Inc. (ELTX): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$2.30M
Year ended 2022-12-31
$28.31M2020-12-31: $2.88M2021-12-31: $28.31M2022-12-31: $2.30M$2.30M
2020-12-31 Revenue (USD) 2022-12-31
Period endedRevenueChange YoYSource filing
2022-12-31$2.30M-91.9%2023-03-17, From 2022-01-01
2021-12-31$28.31M+883.1%2023-03-17, From 2021-01-01
2020-12-31$2.88Mn/a2022-03-30, From 2020-01-01